| Literature DB >> 31444012 |
Bo Xu1, Xiao-Qing Shi2, Run-Lin Xing3, Yan-Cheng Xiao4, Peng Wu5, Pei-Min Wang6.
Abstract
OBJECTIVE: The aim of this meta-analysis was to clarify the role of Interleukin-1 receptor antagonist gene (IL1-RN) Variable Number of Tandem Repeats (VNTR) polymorphism on the risk of OA by means of meta-analysis.Entities:
Keywords: IL1-RN; Meta-analysis; Osteoarthritis; Polymorphism; VNTR
Mesh:
Substances:
Year: 2019 PMID: 31444012 PMCID: PMC6939037 DOI: 10.1016/j.aott.2019.07.004
Source DB: PubMed Journal: Acta Orthop Traumatol Turc ISSN: 1017-995X Impact factor: 1.511
Fig. 1Flowchart of the study selection.
Characteristics of studies included in IL1-RN VNTR polymorphism and OA.
| Study | Ethnicity | Design | Phenotype | Quality score | Patients | Controls | PHWE | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 2L | LL | 2 | L | 22 | 2L | LL | 2 | L | ||||||
| Sezgin 2007 | Caucasian | PCC | Knee | 5 | 4 | 20 | 83 | 28 | 186 | 3 | 13 | 51 | 19 | 115 | 0.09 |
| Jotanovic 2012 | Caucasian | HCC | Knee | 5 | 23 | 86 | 108 | 132 | 302 | 45 | 184 | 266 | 265 | 709 | 0.11 |
| Jotanovic 2011 | Caucasian | PCC | Hip | 4 | 25 | 81 | 126 | 131 | 333 | 44 | 177 | 266 | 265 | 709 | 0.06 |
| Ni 2009 | Asian | HCC | Knee | 3 | 4 | 56 | 393 | 64 | 842 | 2 | 65 | 420 | 69 | 905 | 0.75 |
| Meulenbelt 2004 | Caucasian | PCC | Hip | 5 | 8 | 32 | 25 | 48 | 82 | 50 | 311 | 475 | 411 | 1261 | 0.92 |
| Stern 2003 | Caucasian | HCC | Hand | 6 | 10 | 22 | 36 | 42 | 94 | 4 | 23 | 23 | 31 | 69 | 0.59 |
| Moos 2000 | Caucasian | HCC | Mixed | 4 | 9 | 17 | 19 | 35 | 55 | 12 | 80 | 144 | 104 | 368 | 0.83 |
Quality score was determined by using the Newcastle–Ottawa quality assessment scale.
HWE: Hardy-Weinberg equilibrium.
HCC: Hospital-based case-control study; PCC: Population-based case-control study.
Fig. 2Forest plot of the association between IL1-RN VNTR polymorphism and OA (2 vs L).
Stratification analyses of genetic susceptibility of IL1-RN VNTR polymorphism to OA.
| Category | n | Additive (22 vs LL) | Dominant (22+2L vs LL) | Recessive (22 vs 2L + LL) | Allelic contrast (2 vs L) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I2(%) | P | OR (95%CI) | P | I2(%) | P | OR (95%CI) | P | I2(%) | P | OR (95%CI) | P | I2(%) | P | OR (95%CI) | P | ||
| Total | 7 | 46.8 | 0.08 | 1.56 (1.15, 2.12) | 0.004 | 49.9 | 0.06 | 0.87 (0.73,1.02) | 0.08 | 32.8 | 0.18 | 1.50 (1.12,2.02) | 0.007 | 58.8 | 0.02 | 1.20 (1.05,1.36) | 0.007 |
| Phenotype | |||||||||||||||||
| Knee | 3 | 0.0 | 0.72 | 1.26 (0.77, 2.07) | 0.35 | 0.0 | 0.67 | 0.94 (0.75,1.19) | 0.62 | 0.0 | 0.71 | 1.22 (0.76, 1.97) | 0.44 | 0.0 | 0.65 | 1.09 (0.90, | 0.39 |
| Hip | 2 | 70.2 | 0.07 | 1.49 (0.94, 2.35) | 0.09 | 82.2 | 0.02 | 0.81 (0.62,1.05) | 0.12 | 34.8 | 0.22 | 1.41 (0.91,2.19) | 0.12 | 81.8 | 0.02 | 1.23 (1.00, | 0.05 |
| Ethnicity | |||||||||||||||||
| Asian | 1 | / | / | 2.14 (0.39, 11.73) | 0.38 | / | / | 1.04 (0.72,1.52) | 0.82 | / | / | 2.16 (0.39,11.85) | 0.38 | / | / | 1.00 (0.70, | 0.99 |
| Caucasian | 6 | 55.3 | 0.05 | 1.54 (1.13, 2.11) | 0.006 | 53.6 | 0.06 | 0.83 (0.69,0.99) | 0.04 | 43.1 | 0.12 | 1.48 (1.10,2.00) | 0.01 | 62.3 | 0.02 | 1.23 (1.07, | 0.004 |
| Design | |||||||||||||||||
| HCC | 4 | 56.8 | 0.07 | 1.72 (1.12,2.64) | 0.01 | 47.5 | 0.13 | 0.89 (0.71,1.10) | 0.27 | 53.4 | 0.09 | 1.66 (1.10,2.50) | 0.02 | 63.6 | 0.04 | 1.20 (1.01, | 0.04 |
| PCC | 3 | 49.7 | 0.14 | 1.41 (0.91,2.20) | 0.12 | 67.5 | 0.05 | 0.84 (0.65,1.07) | 0.16 | 0.0 | 0.36 | 1.35 (0.89,2.07) | 0.16 | 68.0 | 0.04 | 1.19 (0.98, | 0.08 |
I2 0–25, no heterogeneity; 25–50, modest heterogeneity; 50 high heterogeneity.
Number of studies.
P value for heterogeneity test.
Random effect model was used when a P value < 0.05 for heterogeneity test; otherwise, fixed effect model was used.
P value for each test.
Fig. 3Funnel plot for publication bias test (2 vs L).